Bold Debates on the Future of Thrombectomy in Stroke: ESOC 2025
European Stroke Organisation (ESO) shared an insightful post on X:
”Couldn’t attend live? Explore one of the key discussions from Day 2 at ESOC 2025 in Helsinki. Our guests debate large core trial results: Are questions still open? Should thrombectomy be for all?”
Watch the key discussions here.
At ESOC 2025 in Helsinki, one of the key discussions on Day 2 centered on the evolving evidence from large core stroke trials.
Experts Anne Hege Nymoen Aamodt and Götz Thomalla debated whether current results fully address the complexities of patient selection and whether thrombectomy should be expanded to all patients.
The session highlighted ongoing uncertainties and the need for further research to refine treatment strategies in this challenging stroke population.
Do not miss the latest updates on global discussions, stay tuned with Hemostasis Today.
-
Feb 17, 2026, 09:04Mahesan Subramaniam: A Heart Attack Is a Long Story That Ends Fast
-
Feb 16, 2026, 15:44Lakmali Silva: Silva Lab Showcases Research at the Gordon Research Conference on Plasminogen and Extracellular Proteolysis
-
Feb 16, 2026, 15:36Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
-
Feb 16, 2026, 15:34Sevak Mirabyan: Advancing Cancer Care Through Knowledge, Collaboration, and Early Diagnosis in Armenia
-
Feb 16, 2026, 15:29Chokri Ben Lamine: Key Clinical Insights of Drug Induced Thrombocytopenia
-
Feb 16, 2026, 15:28Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety
-
Feb 16, 2026, 15:24Flora Peyvandi: Highlighting Overdose, Homicide, and Suicide as Causes of Maternal Death in the US
-
Feb 16, 2026, 14:53Wafaa Abougabal: Differential Diagnosis of Acute Neurologic Deficits and Stroke in PICU
-
Feb 16, 2026, 14:49Nayab Ahmed: Synthesis of ATP and Its Significance in Storage of Blood